Allergic contact dermatitis in children: Common allergens and treatment: A review

Current Opinion in Pediatrics

Volumn 21, Issue 4, 2009, Pages 491-498

  Lee, Pristine W ^a   Elsaie, Mohamed L ^b   Jacob, Sharon E ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Allergic contact dermatitis; Children; Contact allergens; Contact allergy; Patch testing

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; AZATHIOPRINE; BALSAM PERU; CHROMIC ACID; COBALT; COCAMIDOPROPYL BETAINE; CORTICOSTEROID; CYCLOSPORIN; DISULFIRAM; DYE; EMOLLIENT AGENT; FORMALDEHYDE; LANOLIN; METHOTREXATE; NEOMYCIN; NICKEL; PHENYLENEDIAMINE DERIVATIVE; PIMECROLIMUS; TACROLIMUS; THIOMERSAL;

CHILD; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CREAM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; OINTMENT; PATCH TEST; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY;

ALLERGENS; CALCINEURIN; CHILD; CHILD, PRESCHOOL; DERMATITIS, CONTACT; GLUCOCORTICOIDS; HISTAMINE ANTAGONISTS; HUMANS; PATCH TESTS; TREATMENT OUTCOME;

EID: 68949169041     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32832d2008     Document Type: Review

References (109)

1. Brasch J. Contact allergy in children [in German]. Hautarzt 2009; 60:194-196, 198-199.
2. Roul S, Ducombs G, Taieb A. Usefulness of the European standard series for patch testing in children. A 3-year single-centre study of 337 patients. Contact Dermatitis 1999; 40:232-235.
3. Pevny I, Brennenstuhl M, Razinskas G. Patch testing in children. (I) Collective test results: skin testability in children. Contact Dermatitis 1984; 11:201-206.
4. Hogeling M, Pratt M. Allergic contact dermatitis in children: the Ottawa hospital patch-testing clinic experience, 1996 to 2006. Dermatitis 2008; 19:86-89.
5. Bruckner AL, Weston WL, Morelli JG. Does sensitization to contact allergens begin in infancy? Pediatrics 2000; 105:e3.
6. Wantke F, Hemmer W, Jarisch R, Gotz M. Patch test reactions in children, adults and the elderly. A comparative study in patients with suspected allergic contact dermatitis. Contact Dermatitis 1996; 34:316-319.
7. Jacob SE, Brod BA, Crawford GH. Clinically relevant patch test reactions in children: a United States based study. Pediatr Dermatol 2008; 25:520-527
8. Heine G, Schnuch A, Uter W, Worm M. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. Contact Dermatitis 2004; 51:111-117.
9. Zug KA, McGinley-Smith D, Warshaw EM, et al. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004. Arch Dermatol 2008; 144:1329-1336.
10. Kutting B, Brehler R, Traupe H. Allergic contact dermatitis in children: strategies of prevention and risk management. Eur J Dermatol 2004; 14:80-85.
11. Silverberg NB, Licht J, Friedler S, et al. Nickel contact hypersensitivity in children. Pediatr Dermatol 2002; 19:110-113.
12. Kasteler JS, Petersen MJ, Vance JE, Zone JJ. Circulating activated T lymphocytes in autoeczematization. Arch Dermatol 1992; 128:795-798.
13. de Waard-van der Spek FB, Oranje AP. Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of literature. Dermatology 2009; 218:119-125.
14. Jacob SE, Steele T, Brod B, Crawford GH. Dispelling the myths behind pediatric patch testing: experience from our tertiary care patch testing centers. Pediatr Dermatol 2008; 25:296-300.
15. Jacob SE, Burk CJ, Connely EA. Patch testing: another steroid-sparing agent to consider in children. Pediatr Dermatol 2008; 25:81-87.
16. Buckley DA, Rycroft RJG, White IR, McFadden JP. The frequency of fragrance allergy in patch-tested patients increases with their age. Br J Dermatol 2003; 149:986-989.
17. Fernandez Vozmediano JM, Armario Hita JC. Allergic contact dermatitis in children. J Eur Acad Dermatol Venereol 2005; 19:42-46.
18. Romaguera C, Vilaplana J. Contact dermatitis in children: 6 years experience (1992-1997). Contact Dermatitis 1998; 39:277-280.
19. Lewis VJ, Statham BN, Chowdhury MMU. Allergic contact dermatitis in 191 consecutively patch tested children. Contact Dermatitis 2004; 51:155-156.
20. Seidenari S, Giusti F, Pepe P, Mantovani L Contact sensitization in 1094 children undergoing patch testing over a 7-year period. Pediatr Dermatol 2005; 22:1-5.
21. Duarte I, Lazzarini R, Kobata CM. Contact dermatitis in adolescents. Am J Contact Dermatitis 2003; 14:200-204.
22. Giordano-Labadie F, Rance F, Pellegrin F, etal. Frequency of contact allergy in children with atopic dermatitis: results of a prospective study of 137 cases. Contact Dermatitis 1999; 40:192-195.
23. Wohrl S, Hemmer W, Focke M, etal. Patch testing in children, adults, and the elderly: influence of age and sex on sensitization patterns. Pediatr Dermatol 2003; 20:119-123.
24. Kohl L, Blondeel A, Song M. Allergic contact dermatitis from cosmetics. Dermatology 2002; 204:334-337.
25. Beattie PE, Green C, Lowe G, Lewis-Jones MS. Which children should we patch test? Clin Exp Dermatol 2006; 32:6-11.
26. Pratt MD, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 2001 -2002 study period. Dermatitis 2004; 15:176-183.
27. Dotterud LK, Falk ES. Metal allergy in north Norwegian school children and its relationship with ear piercing and atopy. Contact Dermatitis 1994; 31:308-313.
28. Nakamura M, Arima Y, Nobuhara S, Miyachi Y. Nickel allergy in a trumpet player. Contact Dermatitis 1999; 40:219-220.
29. Freeman S, Stephens R. Cheilitis: analysis of 75 cases referred to a contact dermatitis clinic. Am J Contact Dermat 1999; 10:198-200.
30. Wohrl S, Jandl T, Stingl G, Kinaciyan T. Mobile telephone as new source for nickel dermatitis. Contact Dermatitis 2007; 56:113.
31. Livideanu C, Giordano-Labadie F, Paul C. Cellular phone addiction and allergic contact dermatitis to nickel. Contact Dermatitis 2007; 57:130-131.
32. European Parliament and Council Directive 94/27/EC. Annex '28 Nickel CAS No. 7440-0-20 Einecs No.2311114 and its compounds. http://eurex.europa.eu/ smartapi/cgi/sga-doc?smartapi!celexapi!prod!CELEXnumdoc&numdoc= 31994L0027&model=guichett&lg=en. [Accessed 31 July 2008]
33. Jacob SE, Moennich JN, McKean BA, et al. Nickel allergy in the United States: a public health issue in need of a 'nickel directive'. J Am Acad Dermatol 2009; 60:1067-1069.
34. Nguyen SH, Dang TP, MacPherson C, et al. Prevalence of patch test results from 1970 to 2002 in a multicentre population in North America (NACDG). Contact Dermatitis 2008; 58:101-106.
35. Spann CT, Tutrone WD, Weinberg JM, etal. Topical antibacterial agents for wound care: a primer. Dermatol Surg 2003; 29:620-626.
36. Menezes de Padua CA, Schnuch A, Lessmann H, et al. Contact allergy to neomycin sulfate: results of a multifactorial analysis. Pharmacoepidemiol Drug Saf 2005; 14:725-733.
37. Tomar J, Jain VK, Aggarwal K, et al. Contact allergies to cosmetics: testing with 52 cosmetic ingredients and personal products. J Dermatol 2005; 32:951-955.
38. Lerbaek A, Kyvik KO, Menne T, Agner T. Retesting with the TRUE Test in a population-based twin cohort with hand eczema: allergies and persistence in an 8-year follow up study. Contact Dermatitis 2007; 57:248-252.
39. Magnusson B, Wilkinson DS. Cinnamic aldehyde in toothpaste. 1. Clinical aspects and patch tests. Contact Dermatitis 1975; 1:70-76.
40. Strauss RM, Orton DI. Allergic contact cheilitis in the United Kingdom: a retrospective study. Am J Contact Dermat 2003; 14:75-77.
41. Salam TN, Fowler JF Jr. Balsam-related systemic contact dermatitis. J Am Acad Dermatol 2001; 45:377-381.
42. Audicana MT, Munoz D, del Pozo MD, et al. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal. Am J Contact Dermat 2002; 13:3-9.
43. Schafer T, Enders F, Przybilla B. Sensitization to thimerosal and previous vaccination. Contact Dermatitis 1995; 32:114-116.
44. Osawa J, Kitamura K, Ikezawa Z, Nakajima H. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity. Contact Dermatitis 1991; 24:178-182.
45. Breithaup A, Jacob SE. Thimerosal and the relevance of patch-test reactions in children. Dermatitis 2008; 19:275-277.
46. Marks JG Jr, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 1998 to 2000. Am J Contact Dermat 2003; 14:59-62.
47. Freiman A, Al-Layali A, Sasseville D. Patch testing with thimerosal in a Canadian center: an 11-year experience. Am J Contact Dermat 2003; 14:138-143.
48. Brant WT, editor. The metallic alloys: a practical guide for the manufacture of all kinds of alloys, amalgams, and solders, used by metal-workers: together with their chemical and physical properties and their application in the arts and the industries. London: Henry Cary Baird & Co.; 1896.
49. Argonne National Laboratory EVS. Cobalt. Human Health Fact Sheet. Argonne, August 2005. http://www.ead.anl.gov/pub/doc/cobalt.pdf. [Accessed 1 August 2008]
50. Marks JG Jr, Elsner P, DeLeo VA. Standard allergens and contact occupational dermatology. 3rd ed. Philadelphia: Mosby; 2002:; pp. 65-139.
51. Holden CR, Gawkrodger DJ. 10 years' experience of patch testing with a shoe series in 230 patients: which allergens are important? Contact Dermatitis 2005; 53:37-39.
52. Warshaw EM, Schram SE, Belsito DV, et al. Shoe allergens: retrospective analysis of cross-sectional data from the north american contact dermatitis group, 2001-2004. Dermatitis 2007; 18:191-202.
53. Scheman A, Jacob S, Zirwas M, et al. Contact allergy: alternatives for the 2007 North American contact dermatitis group (NACDG) Standard Screening Tray. Dis Mon 2008; 54:7-156.
54. Hamann CP, Rodgers PA, Sullivan K. Allergic contact dermatitis in dental professionals: effective diagnosis and treatment. J Am Dent Assoc 2003; 134:185-194.
55. Bruckner AL, Weston WL. Allergic contact dermatitis in children: a practical approach to management. Skin Therapy Lett 2002; 7:3-5.
56. Hasan T, Rantanen T, Alanko K, et al. Patch test reactions to cosmetic allergens in 1995-1997 and 2000-2002 in Finland: a multicentre study. Contact Dermatitis 2005; 53:40-45.
57. Wakelin SH, Smith H, White IR, et al. A retrospective analysis of contact allergy to lanolin. Br J Dermatol 2001; 145:28-31.
58. Feinman SE. Formaldehyde. In: Guin JD, editor. Practical contact dermatitis. Philadelphia: McGraw-Hill; 1995. pp. 195-210.
59. Rao S, Shenoy SD, Davis S, Nayak S. Detection of formaldehyde in textiles by chromotropic acid method. Indian J Dermatol Venereol Leprol 2004; 70:342-344.
60. Bardana EJ Jr, Montanaro A. Formaldehyde: an analysis of its respiratory, cutaneous, and immunologic effects. Ann Allergy 1991; 66:441-452.
61. Restani P, Campagner P, Fiecchi A, et al. Identification of spinacine as the principal reaction product of gamma-casein with formaldehyde in cheese. Food Chem Toxicol 1988; 26:441-446.
62. Food Standards Agency. Analysis of formaldehyde in shiitake mushrooms (2004). http://www.food.gov.uk/science/research/researchinfo/foodcompo nentsresearch/phytoestrogensresearch/t05-t06programme/t05t06projec tlist/t05027project/. [Accessed 3 August 2008]
63. Food and environmental hygiene department. The Government of Hong Kong special administration region. http://www.fehd.gov.hk/safefood/report/ formaldehyde/formaldehyde.html. [Accessed 3 August 2008]
64. Hill AM, Belsito DV. Systemic contact dermatitis of the eyelids caused by formaldehyde derived from aspartame? Contact Dermatitis 2003; 49:258-259.
65. Jacob SE, Stechschulte S. Formaldehyde, aspartame and migraines: a possible connection. Dermatitis 2008; 19:E10-E11.
66. Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr 2006; 18:385-390.
67. Neri I, Guareschi E, Savoia F, Patrizi A. Childhood allergic contact dermatitis from henna tattoo. Pediatr Dermatol 2002; 19:503-505.
68. Chung WH, Chang YC, Yang LJ, et al. Clinicopathologic features of skin reactions to temporary tattoos and analysis of possible causes. Arch Dermatol 2002; 138:88-92.
69. Brancaccio RR, Brown LH, Chang YT, et al. Identification and quantification of para-phenylenediamine in a temporary black henna tattoo. Am J Contact Dermat 2002; 13:15-18.
70. Jacob SE, Zapolanski T, Chayavichitsilp P, et al. p-phenylenediamine in black henna tattoos: a practice in need of policy in children. Arch Pediatr Adolesc Med 2008; 162:790-792.
71. Leysat SD, Boone M, Blondeel A, Song M. Two cases of cross-sensitivity in subjects allergic to paraphenylenediamine following ingestion of polaronil. Dermatology 2003; 206:379-380.
72. Arroyo MP. Black henna tattoo reaction in a person with sulfonamide and benzocaine allergy. J Am Acad Dermatol 2003; 48:301-302.
73. Sosted H, Johansen JD, Andersen KE, Menne T. Severe allergic hair dye reactions in 8 children. Contact Dermatitis 2006; 54:87-91.
74. Giusti F, Massone F, Bertoni L, etal. Contact sensitization to disperse dyes in children. Pediatr Dermatol 2003; 20:393-397.
75. Guin JD. Seat-belt dermatitis from disperse blue dyes. Contact Dermatitis 2001; 44:263.
76. Alberta L, Sweeney SM, Wiss K. Diaper dye dermatitis. Pediatrics 2005; 116:e450-e452.
77. Batchelor RJ, Wilkinson SM. Contact allergy to disperse dyes in plastic spectacle frames. Contact Dermatitis 2006; 54:66-67.
78. Pratt M, Taraska V. Disperse blue dyes 106 and 124 are common causes of textile dermatitis and should serve as screening allergens for this condition. Am J Contact Dermat 2000; 11:30-41.
79. de Groot AC, van der Walle HB, Weyland JW. Contact allergy to cocami-dopropyl betaine. Contact Dermatitis 1995; 33:419-422.
80. Fowler JF, Fowler LM, Hunter JE. Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study. Contact Dermatitis 1997; 37:276-281.
81. Fowler JFJr,Zug KM, Taylor JS, etal. Allergy to cocamidopropyl betaine and amidoamine in North America. Dermatitis 2004; 15:5-6.
82. Foti C, Bonamonte D, Mascolo G, et al. The role of 3-dimethylaminopropy- lamine and amidoamine in contact allergy to cocamidopropylbetaine. Contact Dermatitis 2003; 48:194-198.
83. Angelini G, Foti C, Rigano L, Vena GA. 3-dimethylaminopropylamine: a key substance in contact allergy to cocamidopropylbetaine? Contact Dermatitis 1995; 32:96-99.
84. Hunter JE, Fowler JF. Safety to human skin of cocamidopropyl betaine: a mild surfactant for personal-care products. J Surf Det 1998; 1:235-239.
85. Cohen DE, Brancaccio R. What is new in clinical research in contact dermatitis? Dermatol Clin 1997; 15:137-148.
86. Boffa MJ, Wilkinson SM, Beck HM. Screening for corticosteroid contact hypersensitivity. Contact Dermatitis 1995; 33:149-151.
87. Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol 1989; 121:27-34.
88. Wilkinson SM. Corticosteroid cross-reactions: an alternative view. Contact Dermatitis 2000; 42:59-63.
89. Davis MD, el-Azhary RA, Farmer SA. Results of patch testing to a corticosteroid series: a retrospective review of 1188 patients during 6 years at Mayo Clinic. J Am Acad Dermatol 2007; 56:921-927.
90. Jacob SE, Castanedo-Tardan MP. Pharmacotherapy for allergic contact dermatitis. Expert Opin Pharmacother 2007; 8:2757-2774.
91. Jacob SE, Steele T. Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity. J Am Acad Dermatol 2006; 54:723-727.
92. Scheuer E, Warshaw E. Allergy to corticosteroids: update and review of epidemiology, clinical characteristics, and structural cross-reactivity. Am J Contact Dermat 2003; 14:179-187.
93. Marlene I, Magnus B. Contact allergen of the year: corticosteroids. Dermatitis 2005; 16:3-5.
94. Isaksson M. Corticosteroids. Dermatol Ther 2004; 17:314-320.
95. Isaksson M, Bruze M. Corticosteroids. Dermatitis 2005; 16:3-5.
96. Lepoittevin JP, Drieghe J, Dooms-Goossens A. Studies in patients with corticosteroid contact allergy: understanding cross-reactivity among different steroids. Arch Dermatol 1995; 131:31-37.
97. Matura M, Goossens A. Contact allergy to corticosteroids. Allergy 2000; 55:698-704.
98. Ohi T. Contact dermatitis due to topical steroids with conceivable cross reactions between topical steroid preparations. J Dermatol 1996; 23:200-208.
99. Rietschel RL Patch testing for corticosteroid allergy in the United States. Arch Dermatol 1995; 131:91-92.
100. Rietschel RL, Fowler JF, Fisher AA, editors. Fisher's contact dermatitis. 4th ed. Baltimore: Lippincott Williams & Wilkins; 1995.
101. Caperton C, Jacob SE. Improving postpatch-test education with the contact allergen replacement database. Dermatitis 2007; 18:101-102.
102. Rietschel RL, Fowler JF, editors. Fisher's contact dermatitis. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 715-721.
103. Coloe J, Zirwas MJ. Allergens in corticosteroid vehicles. Dermatitis 2008; . 19:38-42.
104. Belsito D, Wilson DC, Warshaw E, etal. A prospective randomized clinical trial of 0.1 % tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol 2006; 55:40-46.
105. Wahn U, Bos JD, Goodfield M, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002; 110:e2.
106. Schmutz JL, Barbaud A, Tréchot P. Contact allergy with tacrolimus then pimecrolimus [in French]. Ann Dermatol Venereol 2008; 135:89.
107. Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol 2000; 25:559-566.
108. Shaw DW, Maibach HI, Eichenfield LF. Allergic contact dermatitis from pimecrolimus in a patient with tacrolimus allergy. J Am Acad Dermatol 2007; 56:342-345.
109. Brasch J. Contact allergy in children. Hautarzt 2009; 60:194-196.